Herpes Zoster
📧 Sign up to get email alerts when something new happens for Herpes Zoster.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster [Phase 2]
Phase 2 trial evaluating peginterferon for herpes zoster has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 Years [Phase 1, Phase 2]
Clinical trial update on a zoster vaccine in healthy adults aged 40 and older (Phase 1/Phase 2) completed.
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune Response [Phase 3]
A Phase 3 trial by GlaxoSmithKline evaluated the long-term immune response to its herpes zoster subunit vaccine in adults who had kidney tra…
-
FDA approval · 2023-11-21FDA Approved: ACYCLOVIR — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved the original application for acyclovir by Alembic Pharmaceuticals Inc., making a generic version of the antiviral available.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine [Phase 3]
Phase 3 trial evaluating immune response and safety when shingles vaccine and influenza vaccine are given together or after a COVID-19 boost…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine [Phase 3]
Phase 3 clinical study evaluating protective efficacy and safety of a recombinant herpes zoster vaccine is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: NPC-06 to Pain Associated With Acute Herpes Zoster [Phase 3]
Phase 3 clinical trial update for NPC-06 addressing pain associated with acute herpes zoster has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX) [Phase 2]
A Phase 2 trial examining age-related differences in immune responses to influenza and herpes zoster vaccines (INFLUENZA-SHINGRIX) has compl…
-
FDA approval · 2023-06-07FDA Approved: FAMCICLOVIR — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for Macleods Pharmaceuticals Limited to market famciclovir (FAMCICLOVIR) as a generic. This expa…
-
FDA approval · 2023-05-11FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for valacyclovir hydrochloride (generic valacyclovir) from Mylan Pharmaceuticals Inc., under AND…
-
FDA approval · 2023-05-08FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for Valacyclovir hydrochloride from Aurobindo Pharma Limited. The approval confirms continued market…
-
FDA approval · 2023-04-17FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved a supplemental application for valacyclovir hydrochloride submitted by Jubilant Cadista Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: Non-inferiority Study of ZK-A03 in Treatment of Herpes Zoster Before and After the Alteration of the Active Ingredient Manufacturer [Phase 3]
A Phase 3 non-inferiority trial evaluating ZK-A03 for herpes zoster following an alteration of the active ingredient manufacturer; current s…
-
FDA approval · 2023-03-23FDA Approved: VALACYCLOVIR — Supplemental Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)
FDA approved a supplemental application for valacyclovir from Sun Pharmaceutical Industries, a generic antiviral indicated for herpes infect…
-
FDA approval · 2023-03-09FDA Approved: ACYCLOVIR SUSPENSION — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved ACYCLOVIR SUSPENSION under Original Application for a generic acyclovir suspension by Novadoz Pharmaceuticals LLC.
-
FDA approval · 2023-02-28FDA Approved: ACYCLOVIR — Original Application (Viona Pharmaceuticals Inc)
The FDA approved an Original Application (ANDA) for acyclovir by Viona Pharmaceuticals Inc, establishing a generic version of the antiviral …
-
FDA approval · 2023-02-23FDA Approved: VALACYCLOVIR — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for Valacyclovir by Quallent Pharmaceuticals Health LLC under ANDA203047, indicating a regulatory up…
-
FDA approval · 2022-08-18FDA Approved: ACYCLOVIR — Original Application (Advagen Pharma Limited)
FDA approves the original ANDA for acyclovir from Advagen Pharma Limited.
-
FDA approval · 2022-07-01FDA Approved: ACYCLOVIR — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' original ANDA for generic acyclovir, enabling brand-generic competition for this antiviral. The approva…
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: Study on Efficacy of Attenuated Zoster Vaccine, Live [Phase 3]
Phase 3 clinical trial evaluating the efficacy of an attenuated live zoster vaccine for herpes zoster has been completed.
-
FDA approval · 2021-11-15FDA Approved: ACYCLOVIR — Original Application (Solco Healthcare US, LLC)
FDA approved the original application for acyclovir from Solco Healthcare US, LLC (oral generic).
-
FDA approval · 2021-11-01FDA Approved: ACYCLOVIR — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals LLC's supplemental application for acyclovir.
-
FDA approval · 2021-07-16FDA Approved: AVACLYR — Supplemental Application (Fera Pharmaceuticals, LLC)
The FDA approved a supplemental application for AVACLYR (acyclovir) from Fera Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2021-06-28Clinical Trial Update: Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes Zoster [Phase 4]
Phase 4 trial update assessing efficacy and safety of foscarnet sodium and sodium chloride injection in patients with herpes zoster.
-
FDA approval · 2021-05-19FDA Approved: ACYCLOVIR — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original ANDA for acyclovir from Macleods Pharmaceuticals Limited, enabling a generic version of acyclovir to enter the mar…